Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in PDD and DLB
NCT00855686Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Jan 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in Parkinson's disease dementia (PDD), dementia with Lewy bodies (DLB), sponsored by Lundbeck. Started Jan 2007; status: completed.
02
Drugs
memantine
03
Conditions
Parkinson's disease dementia (PDD)dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT00855686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855686.